P
US8236288B2ActiveUtilityPatentIndex 88

Melanin modification compositions and methods of use

Assignee: MEHTA RAHUL CPriority: Jan 7, 2011Filed: Jan 6, 2012Granted: Aug 7, 2012
Est. expiryJan 7, 2031(~4.5 yrs left)· nominal 20-yr term from priority
Inventors:MEHTA RAHUL CMAKINO ELIZABETH TSIN HOSONTI SUJATHA DGARRUTO JOHN A
A61P 39/06A61P 43/00A61P 29/00A61P 17/00A61P 17/10A61P 17/18A61K 8/9722A61K 8/9794A61K 8/9789A61K 36/484A61K 8/35A61K 31/375A61K 31/445A61K 31/122A61K 2300/00A61K 8/671A61K 8/4926A61K 2800/92A61Q 19/02A61K 31/07A61K 31/047A61K 8/97A61K 8/33
88
PatentIndex Score
15
Cited by
128
References
9
Claims

Abstract

A method for the modification of melanin distribution, and the composition thereof to modify melanin distribution are disclosed. A method for the reduction of melanin distribution, and the composition thereof to reduce melanin distribution are disclosed. A representative composition comprises 4-ethoxybenzaldehyde and one or more additional active agents as well as a pharmaceutically acceptable carrier or excipient. Carriers and excipients may be formulated for topical administration. Compositions may also be formulated for transdermal administration. The compositions may be used for the prevention and treatment of pigmentation disorders, by way of non-limited example, post-inflammatory hyperpigmentation and others. The compositions may be used for lightening skin.

Claims

exact text as granted — not AI-modified
1. A method of lightening skin in an individual in need thereof, comprising administering to the individual in need thereof an effective amount of a composition comprising: a skin-lightening effective amount of a substituted benzaldehyde of from about 0.1% to about 0.5% 4-ethoxybenzaldehyde, from about 0.01% to about 5.0% each of retinol, niacinamide, tetrahexyldecyl ascorbate, glycyrrhiza glabra (licorice) root extract, hexyl resorcinol, and ethyl linoleate, and a pharmaceutically or cosmetically acceptable carrier. 
     
     
       2. The method of  claim 1 , wherein the substituted benzaldehyde composition reduces melanin distribution from about 10% to about 40%. 
     
     
       3. The method of  claim 1 , wherein the composition is topically or transdermally administered to the skin of the individual. 
     
     
       4. The method of  claim 1 , wherein the pharmaceutically or cosmetically acceptable carrier is a topical carrier. 
     
     
       5. The method of  claim 1 , wherein the pharmaceutically or cosmetically acceptable topical carrier is a water-in-oil emulsion, cream, liquid, gel, oil, paste, ointment, suspension, foam, lotion, oil-in-water emulsion, water-in-oil-in-water emulsion, water-in-silicone emulsion, spray or serum carrier. 
     
     
       6. The method of  claim 1 , wherein the composition further comprises one or more additional active agents. 
     
     
       7. The method of  claim 6 , wherein the additional active agent is an antioxidant, a sunscreen, a sunprotectant, a sunblock, a skin-lightening agent, an anti-inflammatory agent, an anti-acne agent or mixtures thereof. 
     
     
       8. The method of  claim 7 , wherein the antioxidant is selected from the group of vitamin E, Coenzyme Q10, idebenone, lycopene, green tea polyphenols, silybin, resveratrol, grape seed extract, Oregon grape root ( Mahonia aquifolium ) extract, pomegranate extract, genistein, pycnogenol, curcumin, curcuminoids, tocopherol, dunaliella salina extract or combinations thereof. 
     
     
       9. The method of  claim 7 , wherein the skin-lightening agent is selected from the group of hydroquinone, monobenzyl ether of hydroquinone, azelaic acid, kojic acid, mequinol, retinoids, soy proteins, alpha-hydroxy acids, trichloroacetic acid, salicylic acid, hydroquinone-beta-D-glucopyranoside, paper mulberry, glabridin, 4-isopropylcetchol, aleosin, N-acetyl-4-S-cycteaminylphenol, N-propionyl-4-S-cysteaminylphenol, N-acetyl glucosamine, tranexaminc acid, undecylenoyl phenylalanine, an alpha melanocyte stimulating hormone antagonist, phytic acid, or combinations thereof.

Cited by (0)

No later patents cite this yet.

References (0)

No backward citations on record.